Histological and Physiological Studies of the Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Bleomycin Induced Lung Fibrosis in Adult Albino Rats

다국어 초록 (Multilingual Abstract)

Background: Lung fibrosis is considered as an end stage for many lung diseases including lung inflammatory disease, autoimmune diseases and malignancy. There are limited therapeutic options with bad prognostic outcome. The aim of this study was to explore the effect of mesenchymal stem cells (MSCs) derived from bone marrow on Bleomycin (BLM) induced lung fibrosis in albino rats.


Methods: 30 adult female albino rats were distributed randomly into 4 groups; negative control group, Bleomycin induced lung fibrosis group, lung fibrosis treated with bone marrow-MSCs (BM-MSCs) and lung fibrosis treated with cell free media. Lung fibrosis was induced with a single dose of intratracheal instillation of BLM. BM-MSCs or cell free media were injected intravenously 28 days after induction and rats were sacrificed after another 28 days for assessment. Minute respiratory volume (MRV), forced vital capacity (FVC) and forced expiratory volume 1 (FEV1) were recorded using spirometer (Power lab data acquisition system). Histological assessment was performed by light microscopic examination of H&E, and Masson’s trichrome stained sections and was further supported by morphometric studies. In addition, electron microscopic examination to assess ultra-structural changes was done. Confocal Laser microscopy and PCR were used as tools to ensure MSCs homing in the lung.


Results: Induction of lung fibrosis was confirmed by histological examination, which revealed disorganized lung architecture, thickened inter-alveolar septa due excessive collagen deposition together with inflammatory cellular infiltration. Moreover, pneumocytes depicted variable degenerative changes. Reduction in MRV, FVC and FEV1 were recorded. BM-MSCs treatment showed marked structural improvement with minimal cellular infiltration and collagen deposition and hence restored lung architecture, together with lung functions.


Conclusion: MSCs are promising potential therapy for lung fibrosis that could restore the normal structure and function of BLM induced lung fibrosis.

다국어 초록 (Multilingual Abstract)

Background: Lung fibrosis is considered as an end stage for many lung diseases including lung inflammatory disease, autoimmune diseases and malignancy. There are limited therapeutic options with bad prognostic outcome. The aim of this study was to explore the effect of mesenchymal stem cells (MSCs) derived from bone marrow on Bleomycin (BLM) induced lung fibrosis in albino rats.




Methods: 30 adult female albino rats were distributed randomly into 4 groups; negative control group, Bleomycin induced lung fibrosis group, lung fibrosis treated with bone marrow-MSCs (BM-MSCs) and lung fibrosis treated with cell free media. Lung fibrosis was induced with a single dose of intratracheal instillation of BLM. BM-MSCs or cell free media were injected intravenously 28 days after induction and rats were sacrificed after another 28 days for assessment. Minute respiratory volume (MRV), forced vital capacity (FVC) and forced expiratory volume 1 (FEV1) were recorded using spirometer (Power lab data acquisition system). Histological assessment was performed by light microscopic examination of H&E, and Masson’s trichrome stained sections and was further supported by morphometric studies. In addition, electron microscopic examination to assess ultra-structural changes was done. Confocal Laser microscopy and PCR were used as tools to ensure MSCs homing in the lung.




Results: Induction of lung fibrosis was confirmed by histological examination, which revealed disorganized lung architecture, thickened inter-alveolar septa due excessive collagen deposition together with inflammatory cellular infiltration. Moreover, pneumocytes depicted variable degenerative changes. Reduction in MRV, FVC and FEV1 were recorded. BM-MSCs treatment showed marked structural improvement with minimal cellular infiltration and collagen deposition and hence restored lung architecture, together with lung functions.




Conclusion: MSCs are promising potential therapy for lung fibrosis that could restore the normal structure and function of BLM induced lung fibrosis.

참고문헌 (Reference)

1 Huleihel L, "Translational research in acute lung injury and pulmonary fibrosis: modified mesenchymal stem cells using miRNA transduction alter lung injury in a bleomycin model" 313 : L92-L103, 2017

2 Bellou V, "Tobacco smoking and risk for idiopathic pulmonary fibrosis: a prospective cohort study in UK Biobank" 50 : PA4887-, 2017

3 Wolters PJ, "Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?" 6 : 154-160, 2018

4 Graham R, "Theory and Practice of Histological Techniques" Churchill-Livingstone 1996

5 Tounekti O, "The ratio of single-to double-strand DNA breaks and their absolute values determine cell death pathway" 84 : 1272-1279, 2001

6 Ghabrial MM, "The possible therapeutic role of mesenchymal stem cells in amiodarone-induced lung injury in adult male albino rats" 46 : 172-, 2018

7 Ying QL, "The ground state of embryonic stem cell self-renewal" 453 : 519-523, 2008

8 Carvajalino S, "Symptom prevalence of patients with fibrotic interstitial lung disease : a systematic literature review" 18 : 78-, 2018

9 Hardjo M, "Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow" 18 : 89-99, 2009

10 Kyurkchiev D, "Secretion of immunoregulatory cytokines by mesenchymal stem cells" 6 : 552-570, 2014

11 Ahmed SK, "Role of bone marrow mesenchymal stem cells in the treatment of CCL4induced liver fibrosis in albino rats : a histological and immunohistochemical study" 7 : 87-97, 2014

12 Hughes KT, "Pulmonary manifestations of acute lung injury : more than just diffuse alveolar damage" 141 : 916-922, 2017

13 Ranu H, "Pulmonary function tests" 80 : 84-, 2011

14 Spagnolo P, "Pulmonary fibrosis secondary to COVID-19: a call to arms?" 8 : 750-752, 2020

15 Decaris ML, "Proteomic analysis of altered extracellular matrix turnover in bleomycin-induced pulmonary fibrosis" 13 : 1741-1752, 2014

16 Shen Q, "Paracrine factors from mesenchymal stem cells attenuate epithelial injury and lung fibrosis" 11 : 2831-2837, 2015

17 Allawzi A, "Oxidative toxicology of bleomycin: role of the extracellular redox environment" 13 : 68-73, 2019

18 Iyer SS, "Oxidation of extracellular cysteine/cystine redox state in bleomycin-induced lung fibrosis" 296 : L37-L45, 2009

19 Chandra S, "Ovarian immature teratoma associated with pregnancy" 18 : 14-, 2019

20 Walters DM, "Mouse models of bleomycin-induced pulmonary fibrosis" (Chapter 5) : 2008

21 Mouratis MA, "Modeling pulmonary fibrosis with bleomycin" 17 : 355-361, 2011

22 Srour N, "Mesenchymal stromal cells in animal bleomycin pulmonary fibrosis models : a systematic review" 4 : 1500-1510, 2015

23 Akram KM, "Mesenchymal stem cells-basics and clinical application II" Springer 105-129, 2012

24 Liu T, "Mesenchymal stem cells inhibited development of lung cancer induced by chemical carcinogens in a rat model" 9 : 2891-2900, 2017

25 Penfornis P, "Mesenchymal stem cells" Springer 159-169, 2016

26 El-Magd MA, "Melatonin maximizes the therapeutic potential of non-preconditioned MSCs in a DEN-induced rat model of HCC" 114 : 108732-, 2019

27 Hay J, "Mechanisms of bleomycin-induced lung damage" 65 : 81-94, 1991

28 Zhang L, "Macrophages: friend or foe in idiopathic pulmonary fibrosis?" 19 : 170-, 2018

29 Ardhanareeswaran K, "Lung stem and progenitor cells" 85 : 89-95, 2013

30 Brandsma CA, "Lung ageing and COPD: is there a role for ageing in abnormal tissue repair?" 26 : 170073-, 2017

31 Drury R, "Light microscope and slide preparation. Carleton’s histological technique" Oxford University Press 1980

32 Davies OG, "Isolation of adipose and bone marrow mesenchymal stem cells using CD29 and CD90 modifies their capacity for osteogenic and adipogenic differentiation" 6 : 2015

33 Zhang L, "Isolation and enrichment of rat mesenchymal stem cells (MSCs) and separation of single-colony derived MSCs" 37 : e1852-, 2010

34 Biehl JK, "Introduction to stem cell therapy" 24 : 98-103, 2009

35 Li W, "In vitro cultivation technology of rat bone marrow mesenchymal stem cells" 9 : 62-68, 2019

36 Khan MR, "Immunophenotypic characterization of ovine mesenchymal stem cells" 89 : 443-450, 2016

37 King CS, "Idiopathic pulmonary fibrosis : effects and optimal management of comorbidities" 5 : 72-84, 2017

38 Kim MS, "IL37 attenuates lung fibrosis by inducing autophagy and regulating TGF-b1 production in mice" 203 : 2265-2275, 2019

39 Orens JB, "General overview of lung transplantation and review of organ allocation" 6 : 13-19, 2009

40 Glauert A, "Fixation, dehydration and embedding of biological specimens. Practical methods in electron microscopy. Part I" North-Holland Publishing Company 1975

41 Liu T, "Fibrosis" Springer 27-42, 2017

42 Karlsen TA, "Expression of inflammatory cytokines in mesenchymal stromal cells is sensitive to culture conditions and simple cell manipulations" 374 : 122-127, 2019

43 Green MR, "Estimation of cell number by hemocytometry counting" 2019

44 Hill C, "Epithelial-mesenchymal transition contributes to pulmonary fibrosis via aberrant epithelial/fibroblastic cross-talk" 3 : 31-35, 2019

45 Wang LJ, "Engraftment assessment in human and mouse liver tissue after sex-mismatched liver cell transplantation by real-time quantitative PCR for Y chromosome sequences" 8 : 822-828, 2002

46 Read CB, "Encyclopedia of statistical sciences" Wiley 2006

47 Bozzola JJ, "Electron Microsocopy Principles and Techniques for Biologists" Jones and Bartlett Publishers, Inc 16-51, 1992

48 Fiorentzis M, "Electrochemotherapy with bleomycin and cisplatin enhances cytotoxicity in primary and metastatic uveal melanoma cell lines in vitro" 65 : 210-215, 2018

49 Nieto MA, "EMT : 2016" 166 : 21-45, 2016

50 Saijo Y., "Drug-Induced Lung Injury" Springer 129-138, 2018

51 Sottocornola R, "Dormancy in the stem cell niche" 3 : 10-, 2012

52 Jalalie L, "Distribution of the CM-Dil-labeled human umbilical cord vein mesenchymal stem cells migrated to the cyclophosphamide-injured ovaries in C57BL/6 mice" 23 : 200-208, 2019

53 Mansouri N, "D97 If you love it, let it go: Exosomes and secretomes" American Thoracic Society A7402-, 2018

54 Lotfy A, "Characterization of mesenchymal stem cells derived from rat bone marrow and adipose tissue : a comparative study" 7 : 135-142, 2014

55 Xia T, "Cells and cellular interactions in the pathogenesis of idiopathic pulmonary fibrosis" 29 : 314-318, 2016

56 McElroy MC, "C75 Fibrosis: current and future approaches: American Thoracic Society" A6365-, 2017

57 Phinney DG, "Building a consensus regarding the nature and origin of mesenchymal stem cells" 38 : 7-12, 2002

58 Reinert T, "Bleomycininduced lung injury" 2013 : 9-, 2013

59 Tounekti O, "Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized" 53 : 5462-5469, 1993

60 Taparra K, "Bleomycin use in the treatment of Hodgkin lymphoma (HL):toxicity and outcomes in the modern era" 1-11, 2019

61 Hecht SM, "Bleomycin : new perspectives on the mechanism of action" 63 : 158-168, 2000

62 Sellares J, "B28 advances in stem cells in injury and repair for 2016: American Thoracic Society" American Thoracic Society A3081-, 2016

63 Zhao Y, "B107 Mechanistic advances in pulmonary fibrosis" American Thoracic Society A4345-, 2018

64 Zaghloul MS, "Attenuation of Bleomycin-induced pulmonary fibrosis in rats by flavocoxid treatment" 4 : 256-263, 2017

65 Dong SH, "Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin(BLM)via suppressing pro-fibrotic and inflammatory signaling pathways" 89 : 1297-1309, 2017

66 Galm U, "Antitumor antibiotics : bleomycin, enediynes, and mitomycin" 105 : 739-758, 2005

67 Sanjabi S, "Anti-inflammatory and pro-inflammatory roles of TGF-b, IL-10, and IL22 in immunity and autoimmunity" 9 : 447-453, 2009

68 Huang S, "An improved protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow" 3 : 26-33, 2015

69 Johannson KA, "Air pollution exposure is associated with lower lung function, but not changes in lung function, in patients with idiopathic pulmonary fibrosis" 154 : 119-125, 2018

70 Egger C, "Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology" 8 : e63432-, 2013

71 Kobzik L, "Acute respiratory distress syndrome" CRC Press 46-58, 2016

72 Oka Y, "A reliable method for intratracheal instillation of materials to the entire lung in rats" 19 : 107-109, 2006